Thrombin generation and implications for hemophilia therapies: A
Por um escritor misterioso
Descrição
Gene therapy for hemophilia A shows promise in phase 3 clinical trial
Using Thrombin Generation Assays to Monitor Hemophilia A Outcomes
Etiology and Incidence Pathophysiology Hemophilia is due to a
Thrombin generation: a global coagulation procedure to investigate
Feasibility of Using Thrombin Generation Assay (TGA) for
Treatment of acute bleeding in acquired haemophilia A with
A mutated factor X activatable by thrombin corrects bleedings in
Novel Insights and New Developments Regarding Coagulation Revealed
Computationally Driven Discovery in Coagulation
Efficacy and safety of fitusiran prophylaxis in people with
Frontiers Thrombin generation assays to personalize treatment in
Concizumab prophylaxis significantly reduces bleeding events for
Thrombin generation (TG) in FVIII inhibitor plasma with a
Tailoring the Effect of Antithrombin-targeting Therapy in
Etiology and Incidence Pathophysiology Hemophilia is due to a
de
por adulto (o preço varia de acordo com o tamanho do grupo)
